Works matching IS 01052896 AND DT 2024 AND VI 328 AND IP 1

Results: 30

The Effector Functions of Antibodies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 6, doi. 10.1111/imr.13428

By:

Daëron, Marc

Publication type:

Article

Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 334, doi. 10.1111/imr.13427

By:

Martineau, Romane;
Susini, Sandrine;
Marabelle, Aurelien

Publication type:

Article

How Technical Advances Changed the Concept of Antibodies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 39, doi. 10.1111/imr.13425

By:

Swiatczak, Bartlomiej;
Greslehner, Gregor P.;
Zach, Martin

Publication type:

Article

Immunoglobulin A Antibodies: From Protection to Harmful Roles.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 171, doi. 10.1111/imr.13424

By:

Gleeson, Patrick J.;
Camara, Niels O. S.;
Launay, Pierre;
Lehuen, Agnès;
Monteiro, Renato C.

Publication type:

Article

Life‐threatening antibodies: The discovery of anaphylaxis.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 24, doi. 10.1111/imr.13415

By:

Daëron, Marc;
Heyman, Birgitta;
Moulin, Anne Marie

Publication type:

Article

Antibodies in breast milk: Pro‐bodies designed for healthy newborn development.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 192, doi. 10.1111/imr.13411

By:

Verhasselt, Valerie;
Tellier, Julie;
Carsetti, Rita;
Tepekule, Burcu

Publication type:

Article

The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 143, doi. 10.1111/imr.13407

By:

Krištić, Jasminka;
Lauc, Gordan

Publication type:

Article

Antibodies in neurological diseases: Established, emerging, explorative.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 283, doi. 10.1111/imr.13405

By:

Li, Lucie Y.;
Keles, Amelya;
Homeyer, Marie A.;
Prüss, Harald

Publication type:

Article

Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 372, doi. 10.1111/imr.13404

By:

Hematianlarki, Marjan;
Nimmerjahn, Falk

Publication type:

Article

Protective role of antibodies in enteric virus infections: Lessons from primary and secondary immune deficiencies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 243, doi. 10.1111/imr.13402

By:

Riller, Quentin;
Schmutz, Muriel;
Fourgeaud, Jacques;
Fischer, Alain;
Neven, Bénédicte

Publication type:

Article

Fc gamma receptors: Their evolution, genomic architecture, genetic variation, and impact on human disease.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 65, doi. 10.1111/imr.13401

By:

Frampton, Sarah;
Smith, Rosanna;
Ferson, Lili;
Gibson, Jane;
Hollox, Edward J.;
Cragg, Mark S.;
Strefford, Jonathan C.

Publication type:

Article

Stellabody: A novel hexamer‐promoting mutation for improved IgG potency.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 438, doi. 10.1111/imr.13400

By:

Whitehead, Clarissa A.;
Wines, Bruce D.;
Davies, Anna M.;
McDonnell, James M.;
Trist, Halina M.;
Esparon, Sandra E.;
Hogarth, P. Mark

Publication type:

Article

Using IMGT unique numbering for IG allotypes and Fc‐engineered variants of effector properties and half‐life of therapeutic antibodies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 473, doi. 10.1111/imr.13399

By:

Lefranc, Marie‐Paule;
Lefranc, Gérard

Publication type:

Article

Enhancing Fc‐mediated effector functions of monoclonal antibodies: The example of HexaBodies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 456, doi. 10.1111/imr.13394

By:

van der Horst, Hilma J.;
Mutis, Tuna

Publication type:

Article

Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 221, doi. 10.1111/imr.13393

By:

Edgar, Julia E.;
Bournazos, Stylianos

Publication type:

Article

From the Gorgon's blood to Behring's Blutserumtherapie: A long path towards serum therapy.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 13, doi. 10.1111/imr.13391

By:

Lahaie, Yves‐Marie;
Watier, Hervé

Publication type:

Article

Pathogenic role of anti‐nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 265, doi. 10.1111/imr.13390

By:

van Oostveen, Wieke M.;
Huizinga, Tom W. J.;
Fehres, Cynthia M.

Publication type:

Article

The Janus (dual) model of immunoglobulin isotype evolution: Conservation and plasticity are the defining paradigms.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 49, doi. 10.1111/imr.13389

By:

Flajnik, Martin F.

Publication type:

Article

Immune checkpoint inhibitors in infectious disease.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 350, doi. 10.1111/imr.13388

By:

King, Hannah A. D.;
Lewin, Sharon R.

Publication type:

Article

The function of antibodies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 113, doi. 10.1111/imr.13387

By:

Daëron, Marc

Publication type:

Article

IgE versus IgG and IgA: Differential roles of allergen‐specific antibodies in sensitization, tolerization, and treatment of allergies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 314, doi. 10.1111/imr.13386

By:

Knol, E. F.;
van Neerven, R. J. J.

Publication type:

Article

Nanobody‐based heavy chain antibodies and chimeric antibodies.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 466, doi. 10.1111/imr.13385

By:

Koch‐Nolte, Friedrich

Publication type:

Article

Natural killer cells and engagers: Powerful weapons against cancer.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 412, doi. 10.1111/imr.13384

By:

Bottino, Cristina;
Picant, Valentin;
Vivier, Eric;
Castriconi, Roberta

Publication type:

Article

Antibody‐mediated control mechanisms of viral infections.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 205, doi. 10.1111/imr.13383

By:

Mackin, Samantha R.;
Sariol, Alan;
Diamond, Michael S.

Publication type:

Article

Single domain antibody: Development and application in biotechnology and biopharma.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 98, doi. 10.1111/imr.13381

By:

Yu, Ting;
Zheng, Fang;
He, Wenbo;
Muyldermans, Serge;
Wen, Yurong

Publication type:

Article

Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 387, doi. 10.1111/imr.13380

By:

Eggel, Alexander;
Pennington, Luke F.;
Jardetzky, Theodore S.

Publication type:

Article

Living in LALA land? Forty years of attenuating Fc effector functions.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 422, doi. 10.1111/imr.13379

By:

Hale, Geoff

Publication type:

Article

Antibodies against endogenous retroviruses.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 300, doi. 10.1111/imr.13378

By:

Chisca, Mihaela;
Larouche, Jean‐David;
Xing, Qi;
Kassiotis, George

Publication type:

Article

Antibody feedback regulation.

Published in:

Immunological Reviews, 2024, v. 328, n. 1, p. 126, doi. 10.1111/imr.13377

By:

Heyman, Birgitta

Publication type:

Article

Issue Information.

Published in:: Immunological Reviews, 2024, v. 328, n. 1, p. 1, doi. 10.1111/imr.13227
Publication type:: Article